Recombinant bone morphogenetic protein (BMP)-2 regulates costochondral growth plate chondrocytes and induces expression of BMP-2 and BMP-4 in a cell maturation-dependent manner

Journal of Orthopaedic Research

Volumn 15, Issue 3, 1997, Pages 371-380

  Erickson, D M ^a   Harris, S E ^a   Dean, D D ^a   Harris, M A ^a   Wozney, J M ^a   Boyan, B D ^a   Schwartz, Z ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; BIOASSAY; BONE; CARTILAGE; DNA; RNA;

BONE MORPHOGENETIC PROTEIN (BMP); CHONDROCYTES; NORTHERN BLOT ANALYSIS;

PROTEINS;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; COLLAGENASE; MESSENGER RNA; PROLINE; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CARTILAGE CELL; CARTILAGE MATRIX; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DNA SYNTHESIS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GROWTH PLATE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; RIB CARTILAGE;

EID: 0031147795     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100150309     Document Type: Article

References (56)

1. 1 Bonewald LF, Kester MB, Schwartz Z, Swain LD, Khare A, Johnson TL, Leach RJ, Boyan BD: Effects of combining transforming growth factor beta and 1.25‐dihydroxyvitamin D 3 on differentiation of a human osteosarcoma (MG‐63). J Biol Chem 267: 8943–8949, 1992
2. 2 Boyan BD, Schwartz Z, Carnes DL Jr, Ramirez V: The effects of Vitamin D metabolites on the plasma and matrix vesicle membranes of growth and resting cartilage cells in vitro. Endocrinology 122: 2851–2860, 1988
3. 3 Boyan BD, Schwartz Z, Swain LD, Carnes DL Jr, Zislis T: Differential expression of phenotype by resting zone and growth region costochondral chondrocytes in vitro. Bone 9: 185–194, 1988
4. 4 Boyan BD, Schwartz Z, Swain LD: In vitro studies on the regulalion of endochondral ossification by vitamin D. Crit Rev Oral Biol Med 3: 15–30, 1992
5. 5 Boyan BD, Swain LD, Schwartz Z, Ramirez V, Carnes DL Jr: Epithelial cell lines that induce bone formation in vivo produce alkaline phosphatase‐enriched matrix vesicles in culture. Clin Orthop 277: 266–276, 1992
6. 6 Boyan BD, Schwartz Z, Swain LD, Khare AG, Heckman JD, Ramirez V, Peters P, Carnes DL Jr: Initial effects of partially purified bone morphogenetic protein on the expression of glycosaminoglycan, collagen, and alkaline phosphatase in nonunion cell cultures. Clin Orthop 278: 286–304, 1992
7. 7 Boyan BD, Schwartz Z, Park‐Snyder S, Dean DD, Yang F, Twardzik D, Bonewald LF: Latent transforming growth factor‐β is produced by chondrocytes and activated by extracellular matrix vesicles upon exposure to 1.25‐(OH) 2 D 3. J Biol Chem 269: 28374–28381, 1994
8. 8 Bretaudiere J, Spillman T: Alkaline phosphatase. In: Methods of Enzymatic Analysis, 3rd ed, pp 75–92. Ed by HU Bergmeyer. Weinheim, Verlag Chemie, 1984
9. 9 Celeste AJ, Lannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM: Identification of transforming growth factor β family members present in bone‐inductive protein purified from bovine bone. Proc Natl Acad Sci USA 87: 9843–9847, 1990
10. 10 Chang SC, Hoang B, Thomas JT, Vukicevic S, Luyten FP, Ryba NJ, Kozak CA, Reddi AH, Moos M Jr. Cartilage‐derived morphogenetic proteins: New members of the transforming growth factor‐beta superfamily predominantly expressed in long bones during human embryonic development. J Biol Chem 269: 28227–28234, 1994
11. 11 Chen P, Carrington JL, Hammonds RG, Reddi AH: Stimulation of chondrogenesis in limb bud mesoderm cells by recombinant human bone morphogenetic protein 2B (BMP‐2B) and modulation by transforming growth factor β1 and β2. Exp Cell Res 195: 509–515, 1991
12. 12 Chen P, Vukicevic S, Sampath TK, Luyten FP: Bovine articular chondrocytes do not undergo hypertrophy when cultured in the presence of serum and osteogenic protein‐1. Biochem Biophys Res Commun 197: 1253–1259, 1993
13. 13 Chen P, Vukicevic S, Sampath TK, Luyten FP: Osteogenic protein‐1 promotes growth and maturation of chick sternal chondrocytes in serum‐free cultures. J Cell Sci 108: 105–114, 1995
14. 14 Chen TL, Bates RL, Dudley A, Hammonds RG Jr, Amento EP: Bone morphogenetic protein‐2b stimulation of growth and osteogenic phenotypes in rat osteoblast‐like cells: comparison with TGF‐β1. J Bone Miner Res 6: 1387–1393, 1991
15. 15 Esquivel A. Schwartz Z. Luna M. Campos R, Dean DD, Boyan BD: Interdependent regulation of chondrocyte differentiation by vitamin D metabolites and TGF‐β. Trans Orihop Res Soc 20: 390, 1995
16. 16 Feng JQ, Harris MA, Ghosh‐Choudhury N, Feng M, Mundy GR. Harris SE: Structure and sequence of mouse bone morphogenetic protein‐2 gene (BMP‐2): comparison of the structures and promoter regions of BMP‐2 and BMP‐4 genes. Biochim Biophys Acta 1218: 221–224, 1994
17. 17 Feng JQ, Chen D, Cooney AJ, Tsai MJ, Harris MA, Tsai SY, Feng M, Mundy GR, Harris SE: The mouse bone morphogenetic protein‐4 gene: analysis of promoter utilization in fetal rat calvarial osteoblasts and regulation by COUP‐TFI orphan receptor. J Biol Chem 270: 28364–28373, 1995
18. 18 Ferguson D, Davis WL, Urist MR, Hurt WC, Allen EP: Bovine bone morphogenetic protein (bBMP) fraction‐induced repair of craniotomy defects in the rhesus monkey (Macaca speciosa). Clin Orthop 219: 251–258, 1987
19. 19 Hale LV, Kemick MLS, Wuthier RE: Effect of vitamin D metabolites on the expression of alkaline phosphatase activity by epiphyseal hypertrophic chondrocytes in primary cell culture. J Bone Miner Res 1: 489–495, 1986
20. 20 Hall JA, Harris MA, Malark M, Mansson PE, Zhou H, Harris SE: Characterization of the hamster DDT1 cell aFGF/HBGF‐I gene and cDNA and its modulation by steroids. J Cell Biochem 43: 17–26, 1990
21. 21 Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ, Ghosh‐Choudhury N, Wozney J, Mundy GR: Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long‐term fetal rat calvarial osteoblasts. J Bone Miner Res 9: 855–863, 1994
22. 22 Harrison ET Jr, Luyten FP, Reddi AH: Osteogenin promotes reexpression of cartilage phenotype by dedifferentiated articular chondrocytes in serum‐free medium. Exp Cell Res 192: 340–345, 1991
23. 23 Heckman JD, Boyan BD, Aufdemorte TB, Abbott JT: The use of bone morphogenetic protein in the treatment of nonunion in a canine model. J Bone Joint Surg [Am] 73: 750–764, 1991
24. 24 Hiraki Y, Inoue H, Shigeno C, Sanma Y, Bentz H, Rosen DM, Asada A, Suzuki F: Bone morphogenetic proteins (BMP‐2 and BMP‐3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic. MC3T3‐E1 cells in vitro. J Bone Miner Res 6: 1373–1385, 1991
25. 25 Holmes S, Schwartz Z, Kieswetter K, Liu Y, Campos R, Sylvia VL, Dean DD, Boyan BD: TGF‐β1 treatment of resting zone chondrocytes induces differentiation into a 1,25‐(OH) 2 D 3 ‐ responsive growth zone chondrocyte phenotype (abstract no. 1949). J Dent Res 75 (Special lssue): 261, 1996
26. 26 Johnson EE, Urist MR, Finerman GA: Bone morphogenetic protein augmentation grafting of resistant femoral nonunions: a preliminary report. Clin Orthop 230: 257–265, 1988
27. 27 Johnson EE, Urist MR, Finerman GA: Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein: a preliminary report. Clin Orthop 236: 249–257, 1988
28. 28 Johnson EE, Urist MR, Finerman GA: Resistant nonunions and partial or complete segmental defects of long bones: treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolysed, antigen‐extracted, allogeneic (AAA) bone. Clin Orthop 277: 229–237, 1992
29. 29 Luyten FP, Yu YM, Yanagishita M, Vukicevic S, Hammonds RG, Reddi AH: Natural bovine osteogenin and recombinant human bone morphogenetic protein‐2B are equipotent in the maintenance of proteoglycans in bovine articular cartilage explant cultures. J Biol Chem 267: 3691–3695, 1992
30. 30 Luyten FP, Chen P, Paralkar V, Reddi AH: Recombinant bone morphogenetic protein‐4, transforming growth factor‐beta 1, and activin A enhance the cartilage phenotype of articular chondrocytes in vitro. Exp Cell Res 210: 224–229, 1994
31. 31 Lyons KM, Pelton RW, Hogan BL: Patterns of expression of murine Vgr‐1 and BMP‐2a RNA suggest that transforming growth factor‐beta‐like genes coordinately regulate aspects of embryonic development. Genes Dev 3: 1657–1658, 1989
32. 32 Lyons KM, Pelton RW, Hogan BLM: Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein‐2A (BMP‐2A). Development 109: 833–844, 1990
33. 33 Massague J: Receptors for the TGF‐ β family. Cell 69: 1067–1070, 1992
34. 34 Nasatzky E, Schwartz Z, Soskolne WA, Brooks BP, Dean DD. Boyan BD, Ornoy A: Sex steroid enhancement of matrix production by chondrocytes is sex and cell maturation specific. Endocr J 2: 207–215, 1994
35. 35 Nilsson OS, Urist MR, Dawson EG, Schmalzried TP, Finerman GA: Bone repair induced by bone morphogenetic protein in ulnar defects in dogs. J Bone Joint Surg [Br] 68: 635–642, 1986
36. 36 O'Keefe RJ, Puzas JE, Brand JS, Rosier RN: Effects of transforming growth factor‐β on matrix synthesis by chick growth plate chondrocytes. Endocrinology 122: 2953–2961, 1988
37. 37 Peterkofsky B, Diegelmann R: Use of a mixture of proteinasefree collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry 10: 988–994, 1971
38. 38 Raisz LG. Lorenzo J. Gworek S, Kream B, Rosenblatt M: Comparison of the effects of a potent synthetic analog of bovine parathyroid hormone with native bPTH‐(l‐84) and synthetic bPTH‐(l‐34) on bone resorption and collagen synthesis. Calcif Tissue Int 29: 215–218, 1979
39. 39 Rosen V, Capparella J, McQuaid D, Cox K, Thies RS, Song J, Wozney J: Development of immortalized cells derived from 13DPC mouse limb buds as a system to study the effects of recombinant human bone morphogenetic protein‐2 (rhBMP‐2) on limb bud cell differentiation. Prog Clin Biol Res 383: 305–315 1993
40. 40 Sambrook J, Fritsch EF, Maniatis T [eds]: Molecular Cloning A Laboratory Manual, 2nd ed. Cold Spring Harbor, New York, Cold Spring Harbor Laboratory Press, 1989
41. 41 Sampath TK, Coughlin JE, Whetstone RM, Banach D, Corbett C, Ridge RJ, Ozkaynak E, Oppermann H, Rueger DC: Bovine osteogenic protein is composed of dimers of OP‐1 and BMP 2A, two members of the transforming growth factor‐β Superfamily. J Biol Chem 265: 13198–13205, 1990
42. 42 Sato K, Urist MR: Bone morphogenetic protein‐induced cartilage development in tissue culture. Clin Orthop 183: 180–187, 1984
43. 43 Schwartz Z, Knight G, Swain LD, Boyan BD: Localization of vitamin D 3 ‐responsive alkaline phosphatase in cultured chondrocytes. J Biol Chem 263: 6023–6026, 1988
44. 44 Schwartz Z, Schlader DL, Ramirez V, Kennedy, MB, Boyan BD: Effects of vitamin D metabolites on collagen production and cell proliferation of growth zone and resting zone carnlage cells in vitro. J Bone Miner Res 4: 199–207, 1989
45. 45 Schwartz Z, Dean DD, Walton JK, Brooks BP, Boyan BD: Treatment of resting zone chondrocytes with 24,25‐dihydroxyvitamin D 3 [24,25‐(OH) 2 D 3 ] induces differentiation in to a 1,25‐(OH) 2 D 3 ‐responsive phenotype characteristic of growth zone chondrocytes. Endocrinology 136: 402–411, 1995
46. 46 Schwartz Z, Hancock RH, Dean DD, Brooks BP, Gomez R, Boskey AL, Balian G, Boyan BD: Dexamethasone promotes von Kossa‐positive nodule formation and increased alkaline phosphatase activity in costochondral chondrocyte cultures Endocr J 3: 351–360, 1995
47. 47 Takagi K, Urist MR: The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects. Ann Surg 196: 100–109, 1982
48. 48 Takiguchi T, Kobayashi M, Suzuki R, Yamaguchi A, Nagumo M, Hasega K: Role of BMP‐2 on synthesis and degradation of collagen (abstract no. 1951), J Dent Res 75 (Special Issue): 261, 1996
49. 49 Urist MR: Bone: formation by autoinduction. Science 150: 893–899, 1965
50. 50 Vukicevic S, Luyten FP, Reddi AH: Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proc Natl Acad Sci USA 86: 8793–8797, 1989
51. 51 Vukicevic S, Helder MN, Luyten FP: Developing human lung and kidney are major sites for synthesis of bone morphogenetic protein‐3 (osteogenin). J Histochem Cytochem 42: 869–875, 1994
52. 52 Wang EA, Israel DI, Kelly S, Luxenberg DP: Bone morphogenetic protein‐2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 9: 57–71, 1993
53. 53 Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewiek RM, Wang EA: Novel regulators of bone formation: molecular clones and activities. Science 242: 1528–1534, 1988
54. 54 Yamaguchi A, Ikeda T, Katagiri T, Suda T, Yoshiki S: BMP‐2 induces differentiation of a non‐osteogenic fibroblastic cell line (C3H10T1/2) into both osteoblasts and chondroblasts in vitro. Bone Miner 175: 191, 1992
55. 55 Yoshida N, Sugiyama E, Morotome Y, Duarte WR, Kasugai S, Ohya K, Ishikawa I: The effects of rhBMP‐2 on cultured human periodontal ligament cells (abstract no. 1950). J Dent Res 75 (Special Issue): 261, 1996
56. 56 Zhou H, Hammonds RG Jr, Findlay DM, Fuller PJ, Martin TJ, Ng KW: Retinoic acid modulation of mRNA levels in malignant, nontransformed, and immortalized osteoblasts. J Bone Miner Res 6: 767–777, 1991